Effects of Aronia Berry on Inflammation in COPD Patients
Consumption of Anti-Inflammatory Effects of Aronia (Aronia Melanocarpa) Berry in Patients With Chronic Obstructive Pulmonary Disease
This study is testing if eating freeze-dried aronia berries can help reduce inflammation in people with COPD.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Amasya University Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Trial ID | NCT06702696 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of freeze-dried aronia berry consumption on inflammatory markers in patients with chronic obstructive pulmonary disease (COPD). Conducted at a research hospital in Istanbul, 50 participants aged 50-80 will be randomly assigned to receive either aronia berry powder or a placebo for 8 weeks. The study will assess various respiratory, biochemical, and anthropometric parameters before and after the intervention, alongside dietary intake records. The aim is to determine if aronia berries can serve as an effective adjunct to standard medical treatment for COPD.
Who should consider this trial
Good fit: Ideal candidates are non-smoking individuals aged 50-80 diagnosed with COPD who are willing to consume aronia berries.
Not a fit: Patients with chronic inflammatory diseases, malignancies, or those who smoke may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a natural dietary intervention to help reduce inflammation and improve respiratory health in COPD patients.
How similar studies have performed: While the use of aronia berries is a novel approach, other studies have shown promise in using dietary interventions to manage inflammation in chronic diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 50-80 years * Diagnosed with COPD * Not following a vegetarian or vegan diet * Willing to consume the provided aronia berry (black chokeberry) * Non-smokers * Have signed the informed consent form * Has not undergone endobronchial tube or valve surgery in the last two years. Exclusion Criteria: * Presence of associated chronic inflammatory/rheumatic diseases * Chronic infections that may create a prothrombotic state * Chronic kidney disease (CKD) * Malignancy * Hereditary thrombophilia * Essential thrombocythemia * Diagnosed endocrine disorders * Malabsorption disorders * Allergy to any food or berry fruits * Smoking * Participants who did not sign the informed consent form
Where this trial is running
Istanbul, Zeytinburnu
- Yedikule Göğüs Hastalıkları Hastanesi — Istanbul, Zeytinburnu, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Buse Sarıkaya, PhD
- Email: buse-sarikaya@hotmail.com
- Phone: 05544615101
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.